LBA6 Phase III trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer (PSMAddition)

S.T. Tagawa, O. Sartor, J.M. Piulats, F. Saad, K. Fizazi, Alison Reid, H. Beltran, Gero Kramer, H. Mahammedi, M. Eiber, Santosh Gupta, D.E. Castellano Gauna, R. Hauke, H. Kim, Cheol Kwak, S-T. Pang, Emmanuel Bouillaud, A. Zhang, Olga V. Sakharova, M.J. Morris